Interestingly, there is a case reported of a patient who underwent liver transplantation, started antiviral therapy for hepatitis C with ribavirin and interferon, received recombinant erythropoietin for anemia, but developed anti-erythropoietin antibody-mediated PRCA while on immunosuppression [17]. The gene discussed is EPO; the disease is hepatitis C virus infection.